117 related articles for article (PubMed ID: 38940590)
41. Deficiency in CCR2 increases susceptibility of mice to infection with an intracellular pathogen, Francisella tularensis LVS, but does not impair development of protective immunity.
Kurtz SL; De Pascalis R; Meierovics AI; Elkins KL
PLoS One; 2021; 16(3):e0249142. PubMed ID: 33760886
[TBL] [Abstract][Full Text] [Related]
42. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
[TBL] [Abstract][Full Text] [Related]
43. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background.
Chen W; Shen H; Webb A; KuoLee R; Conlan JW
Vaccine; 2003 Sep; 21(25-26):3690-700. PubMed ID: 12922099
[TBL] [Abstract][Full Text] [Related]
44. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
[TBL] [Abstract][Full Text] [Related]
45. Aim2 and Nlrp3 Are Dispensable for Vaccine-Induced Immunity against Francisella tularensis Live Vaccine Strain.
Alqahtani M; Ma Z; Fantone K; Malik M; Bakshi CS
Infect Immun; 2021 Jun; 89(7):e0013421. PubMed ID: 33875472
[TBL] [Abstract][Full Text] [Related]
46. Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.
Richard K; Mann BJ; Stocker L; Barry EM; Qin A; Cole LE; Hurley MT; Ernst RK; Michalek SM; Stein DC; Deshong P; Vogel SN
Clin Vaccine Immunol; 2014 Feb; 21(2):212-26. PubMed ID: 24351755
[TBL] [Abstract][Full Text] [Related]
47. Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy.
Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W
PLoS One; 2010 Oct; 5(10):e13349. PubMed ID: 20967278
[TBL] [Abstract][Full Text] [Related]
48. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
Bakshi CS; Malik M; Mahawar M; Kirimanjeswara GS; Hazlett KR; Palmer LE; Furie MB; Singh R; Melendez JA; Sellati TJ; Metzger DW
Vaccine; 2008 Sep; 26(41):5276-88. PubMed ID: 18692537
[TBL] [Abstract][Full Text] [Related]
49. A Francisella tularensis live vaccine strain that improves stimulation of antigen-presenting cells does not enhance vaccine efficacy.
Schmitt DM; O'Dee DM; Horzempa J; Carlson PE; Russo BC; Bales JM; Brown MJ; Nau GJ
PLoS One; 2012; 7(2):e31172. PubMed ID: 22355343
[TBL] [Abstract][Full Text] [Related]
50. Development of functional and molecular correlates of vaccine-induced protection for a model intracellular pathogen, F. tularensis LVS.
De Pascalis R; Chou AY; Bosio CM; Huang CY; Follmann DA; Elkins KL
PLoS Pathog; 2012 Jan; 8(1):e1002494. PubMed ID: 22275868
[TBL] [Abstract][Full Text] [Related]
51. A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge.
Pechous RD; McCarthy TR; Mohapatra NP; Soni S; Penoske RM; Salzman NH; Frank DW; Gunn JS; Zahrt TC
PLoS One; 2008 Jun; 3(6):e2487. PubMed ID: 18575611
[TBL] [Abstract][Full Text] [Related]
52. Comparison of bone marrow-derived and mucosal mast cells in controlling intramacrophage Francisella tularensis replication.
Hunter C; Rodriguez A; Yu JJ; Chambers J; Guentzel MN; Arulanandam B
Exp Biol Med (Maywood); 2012 Jun; 237(6):617-21. PubMed ID: 22688822
[TBL] [Abstract][Full Text] [Related]
53. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine.
Drabick JJ; Narayanan RB; Williams JC; Leduc JW; Nacy CA
Am J Med Sci; 1994 Aug; 308(2):83-7. PubMed ID: 8042659
[TBL] [Abstract][Full Text] [Related]
54. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia.
Golovliov I; Twine SM; Shen H; Sjostedt A; Conlan W
PLoS One; 2013; 8(11):e78671. PubMed ID: 24236032
[TBL] [Abstract][Full Text] [Related]
55. Control of Francisella tularensis Intracellular Growth by Pulmonary Epithelial Cells.
Maggio S; Takeda K; Stark F; Meierovics AI; Yabe I; Cowley SC
PLoS One; 2015; 10(9):e0138565. PubMed ID: 26379269
[TBL] [Abstract][Full Text] [Related]
56. Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity.
Bosio CM; Elkins KL
Infect Immun; 2001 Jan; 69(1):194-203. PubMed ID: 11119506
[TBL] [Abstract][Full Text] [Related]
57. Microbial co-infection alters macrophage polarization, phagosomal escape, and microbial killing.
Trivedi NH; Yu JJ; Hung CY; Doelger RP; Navara CS; Armitige LY; Seshu J; Sinai AP; Chambers JP; Guentzel MN; Arulanandam BP
Innate Immun; 2018 Apr; 24(3):152-162. PubMed ID: 29482417
[TBL] [Abstract][Full Text] [Related]
58. Generation of protection against Francisella novicida in mice depends on the pathogenicity protein PdpA, but not PdpC or PdpD.
Chou AY; Kennett NJ; Nix EB; Schmerk CL; Nano FE; Elkins KL
Microbes Infect; 2013 Nov; 15(12):816-27. PubMed ID: 23880085
[TBL] [Abstract][Full Text] [Related]
59. Macrophage Selenoproteins Restrict Intracellular Replication of
Markley RL; Restori KH; Katkere B; Sumner SE; Nicol MJ; Tyryshkina A; Nettleford SK; Williamson DR; Place DE; Dewan KK; Shay AE; Carlson BA; Girirajan S; Prabhu KS; Kirimanjeswara GS
Front Immunol; 2021; 12():701341. PubMed ID: 34777335
[TBL] [Abstract][Full Text] [Related]
60. IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection.
Roberts LM; Davies JS; Sempowski GD; Frelinger JA
Vaccine; 2014 Jun; 32(29):3595-603. PubMed ID: 24837506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
